KCG
ACUR

Knight Capital Group’s Acura Pharmaceuticals ACUR Stock Holding History

Knight Capital Group’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$31K Buy
+3,356
New +$37.9K ﹤0.01% 3125

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
OWD
Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Knight Capital Group's ACUR Position: Q2 2013 in Review

Knight Capital Group opened a new position in Acura Pharmaceuticals (ACUR) in Q2 2013: 3,356 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #3125 among its holdings.

43 funds tracked by Wall St. Rank hold ACUR as of Q2 2013.

  • Knight Capital Group held 3,356 shares of Acura Pharmaceuticals worth $31K as of Q2 2013.
  • Acura Pharmaceuticals was a new Knight Capital Group position in Q2 2013.
  • Acura Pharmaceuticals made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3125 holding.
  • 43 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.